IVF ResearchNetwork

A study by Eugin’ s laboratories, assisted reproduction and fertility clinics, has identified a number of patterns by which female embryos develop earlier than male embryos.

Researchers at Eugin, the assisted reproduction and fertility group, have developed, in partnership with the CSIC Artificial Intelligence Research Institute, an artificial intelligence algorithm that can identify the optimal dose of medication for ovarian stimulation required by a patient in an in vitro fertilisation cycle.

The research concludes that between April 2020 and 15 January 2021 these clinics maintained lower than 1% COVID-19 positivity among their patients.

The intracytoplasmic sperm injection (ICSI) has established itself as an effective technique in assisted reproduction, but between 1 and 3% of ICSI cycles result in fertilization failures that experts still cannot explain.

The reproductive results of the eggs frozen by the vitrification technique are comparable to those obtained with fresh eggs. This has been made clear in the most wide-ranging comparative study done to date using “sibling” eggs, namely eggs produced by the same woman, in which they analysed a sample of 37,520 fresh and frozen eggs, donated by over 1,800 different women.

Researchers from the Eugin Group have presented the data of a study in which the assisted reproduction ROPA technique (Reception of oocytes from the partner) in female couples seems to have higher success rates than conventional IVF (in vitro fertilization), in which the pregnant woman provides the egg as well.

Patients who turn to assisted reproduction request more research into the side effects of pharmacological treatments, psychological aspects and impact of diet when tackling an infertility problem. As evidenced in the Eugin Group pioneer study of international scope, carried out via a questionnaire which 945 patients (men and women) from their 12 centres in Spain, […]

In Vitro Fertilisation with Pre-implantation Genetic Diagnosis (PGD) allows parents who are carriers of genetic diseases to have healthy children

The scientific journal Human Reproduction (Oxford Journals) has published a study, prepared by international experts, which rejects the therapeutic possibilities of stem cells in the field of human fertility.

Members of the medical and scientific team share their accomplishments in the 72nd edition of the event, which was attended by professionals from all over the world

Our team of professionals takes part in the main meetings of the European Society of Human Reproduction in Milan and Athens

A study carried out by Eugin claims that 2.9% of couples may produce children with serious genetic diseases.

The scientific director, Dr. Rita Vassena, explained the advantages of performing a Genetic Compatibility Test before conceiving a baby.